Efficacy of budesonide orodispersible tablets for induction of remission in patients with active eosinophilic esophagitis: Results from the 6-weeks open-label treatment phase of EOS-2 trial - Schlag, C; Miehlke, S; Lucendo, A (Gastroenterology, 2019)